Search research articles
Contact Us
Filters
Showing results (111-120 of 157) with videos related to
Page
of 16
Sort By:
Anticancer Research
|
April 12, 2012
Effective targeting of the tumor microenvironment for cancer therapy
Ping Jiang, Xiaoming Li, Curtis B Thompson, et al.
Arthritis Research & Therapy
|
June 8, 2010
Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis
Fiona E McCann, Andrew C Palfreeman, Melanie Andrews, et al.
Wellcome Open Research
|
March 7, 2020
Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren's disease, with an embedded dose response study
Jagdeep Nanchahal, Catherine Ball, Jennifer Swettenham, et al.
Pain
|
March 31, 2010
Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain
Kay E McNamee, Annika Burleigh, Luke L Gompels, et al.
Annals of Neurology
|
December 23, 2011
Resolving postoperative neuroinflammation and cognitive decline
Niccolò Terrando, Lars I Eriksson, Jae Kyu Ryu, et al.
Biology Open
|
March 7, 2020
Single cell force profiling of human myofibroblasts reveals a biophysical spectrum of cell states
Thomas B Layton, Lynn Williams, Huw Colin-York, et al.
Arthritis and Rheumatism
|
May 28, 2010
SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis
Stefan K Drexler, Philip Kong, Julia Inglis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 11, 2019
TNF receptor 2 signaling prevents DNA methylation at the <i>Foxp3</i> promoter and prevents pathogenic conversion of regulatory T cells
Wen-Yi Tseng, Yi-Shu Huang, Felix Clanchy, et al.
Arthritis and Rheumatism
|
February 2, 2008
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha
Michael J Elliot, Ravinder N Maini, Marc Feldmann, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 27, 2014
Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis
Fiona E McCann, Dany P Perocheau, Gerhard Ruspi, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 157) with videos related to
Sort By:
Page
of 16
Anticancer Research
|
April 12, 2012
Effective targeting of the tumor microenvironment for cancer therapy
Ping Jiang, Xiaoming Li, Curtis B Thompson, et al.
Arthritis Research & Therapy
|
June 8, 2010
Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis
Fiona E McCann, Andrew C Palfreeman, Melanie Andrews, et al.
Wellcome Open Research
|
March 7, 2020
Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren's disease, with an embedded dose response study
Jagdeep Nanchahal, Catherine Ball, Jennifer Swettenham, et al.
Pain
|
March 31, 2010
Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain
Kay E McNamee, Annika Burleigh, Luke L Gompels, et al.
Annals of Neurology
|
December 23, 2011
Resolving postoperative neuroinflammation and cognitive decline
Niccolò Terrando, Lars I Eriksson, Jae Kyu Ryu, et al.
Biology Open
|
March 7, 2020
Single cell force profiling of human myofibroblasts reveals a biophysical spectrum of cell states
Thomas B Layton, Lynn Williams, Huw Colin-York, et al.
Arthritis and Rheumatism
|
May 28, 2010
SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis
Stefan K Drexler, Philip Kong, Julia Inglis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 11, 2019
TNF receptor 2 signaling prevents DNA methylation at the <i>Foxp3</i> promoter and prevents pathogenic conversion of regulatory T cells
Wen-Yi Tseng, Yi-Shu Huang, Felix Clanchy, et al.
Arthritis and Rheumatism
|
February 2, 2008
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha
Michael J Elliot, Ravinder N Maini, Marc Feldmann, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 27, 2014
Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis
Fiona E McCann, Dany P Perocheau, Gerhard Ruspi, et al.
Page
of 16